hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation

Establishment of Clinical Applicable Human Amniotic Epithelial Cell Products and Its Preliminary Application in Allogeneic Hematopoietic Stem Cell Transplantation

hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation

Establishment of Clinical Applicable Human Amniotic Epithelial Cell Products and Its Preliminary Application in Allogeneic Hematopoietic Stem Cell Transplantation

Inclusion Criteria:

• leukemia patients with allogeneic HSCT
• KFS score >90
• after transplantation, the patient was implanted (peripheral blood neutrophil absolute value >500/ul for 3 consecutive days)
• no uncontrolled infection after transplantation
• activity II above aGVHD
• patients agreed to participate in the study

Exclusion Criteria:

• patients refused to participate in the study
• patients have poor compliance
• has received hormone therapy
• patients had serious heart, lung, liver, kidney and other vital organs damage
• researchers believe that patients who are not suitable for observation study